Overview

A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration

Status:
Completed

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

This phase 4 study will evaluate the feasibility of initiating subjects on VIVITROL in prison and continuing VIVITROL upon release into the community.

Phase:

Phase 4

Details

Lead Sponsor:

Alkermes, Inc.

Treatments:

Naltrexone